MYH7 R453C induced cardiac remodelling via activating TGF-β/Smad2/3, ERK1/2 and Nox4/ROS/NF-κB signalling pathways
Open Biology · 2024
DOI: 10.1098/rsob.230427 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Biology, 2024. Verfasst von Lingyu Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Lab for Zoonoses Research, Ministry of Education, College of Animal Sciences, Jilin University , Changchun 130062, People's Republic of China. Hauptthemen laut MEDLINE: Myosin Heavy Chains, Transforming Growth Factor beta, NADPH Oxidase 4, Reactive Oxygen Species. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Hypertrophic cardiomyopathy (HCM) is a monogenic cardiac disorder commonly induced by sarcomere gene mutations. However, the mechanism for HCM is not well defined. Here, we generated transgenic MYH7 R453C and MYH6 R453C piglets and found both developed typical cardiac hypertrophy. Unexpectedly, we found serious fibrosis and cardiomyocyte loss in the ventricular of MYH7 R453C, not MYH6 R453C piglets, similar to HCM patients. Then, RNA-seq analysis and western blotting identified the activation of ERK1/2 and PI3K-Akt pathways in MYH7 R453C. Moreover, we observed an increased expression of fetal genes and an excess of reactive oxygen species (ROS) in MYH7 R453C piglet models, which was produced by Nox4 and subsequently induced inflammatory response. Additionally, the phosphorylation levels of Smad2/3, ERK1/2 and NF-kB p65 proteins were elevated in cardiomyocytes with the MYH7 R453C mutation. Furthermore, epigallocatechin gallate, a natural bioactive compound, could be used as a drug to reduce cell death by adjusting significant downregulation of the protein expression of Bax and upregulated Bcl-2 levels in the H9C2 models with MYH7 R453C mutation. In conclusion, our study illustrated that TGF-β/Smad2/3, ERK1/2 and Nox4/ROS pathways have synergistic effects on cardiac remodelling and inflammation in MYH7 R453C mutation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Lab for Zoonoses Research, Ministry of Education, College of Animal Sciences, Jilin University , Changchun 130062, People's Republic of China.
- Chongqing Research Institute, Jilin University , Chongqing 401123, People's Republic of China.
- Department of Human Genetics, Radboud University Medical Center , Nijmegen 6525 GA, The Netherlands.
ORCID-Profile: Yi Lu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, L., Li, L., Zhao, D., Yuan, H., Zhang, H., Chen, J., Pang, D., Lu, Y., & Ouyang, H. (2024). MYH7 R453C induced cardiac remodelling via activating TGF-β/Smad2/3, ERK1/2 and Nox4/ROS/NF-κB signalling pathways. Open Biology. https://doi.org/10.1098/rsob.230427
Vancouver
Wang L, Li L, Zhao D, Yuan H, Zhang H, Chen J, et al. MYH7 R453C induced cardiac remodelling via activating TGF-β/Smad2/3, ERK1/2 and Nox4/ROS/NF-κB signalling pathways. Open Biology. 2024. doi:10.1098/rsob.230427
BibTeX
@article{Wang2024,
author = {Wang, Lingyu and Li, Linquan and Zhao, Dazhong and Yuan, Hongming and Zhang, Huanyu and Chen, Jiahuan and Pang, Daxin and Lu, Yi and Ouyang, Hongsheng},
title = {MYH7 R453C induced cardiac remodelling via activating TGF-β/Smad2/3, ERK1/2 and Nox4/ROS/NF-κB signalling pathways},
journal = {Open Biology},
year = {2024},
doi = {10.1098/rsob.230427}
}
EUVIMED